Survival of Clostridium difficile and its toxins in equine feces:: implications for diagnostic test selection and interpretation

被引:45
作者
Weese, JS [1 ]
Staempfli, HR
Prescott, JF
机构
[1] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada
[2] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada
关键词
D O I
10.1177/104063870001200406
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Although Clostridium difficile is recognized as a cause of enterocolitis in horses and humans, there has been little work published regarding the lability of C, difficile and its toxins in feces. A significant decrease in recovery of C. difficile from inoculated equine fecal samples occurred during storage. Recovery after storage in air at 4 degrees C decreased from 76% (37/49) after 24 hours to 67% (33/49) at 48 hours and 29% (14/49) after 72 hours. In contrast to aerobic storage, 25 of 26 samples stored anaerobically at 4 degrees C yielded growth of C. difficile for 30 days, whereas the organism was only detected for 2.5 +/- 2.52 days ((x) over bar +/- SD) in paired samples stored aerobically. The use of an anaerobic transport medium was effective in maintaining viability of C. difficile. These findings indicate that poor aerotolerance is the reason for the rapid decrease in culture yield. In contrast to C. difficile organisms stored aerobically at 4 degrees C, C, difficile toxins were considerably more stable and could be detected by enzyme-linked immunosorbent assay in both broth and inoculated fecal samples for at least 30 days. The poor survival of C. difficile but the stability of its toxins when feces are stored aerobically must be considered when submitting samples for diagnosis of C. difficile-associated enterocolitis in horses and when interpreting laboratory results.
引用
收藏
页码:332 / 336
页数:5
相关论文
共 32 条
[1]   Prevalence and pathogenicity of Clostridium difficile in hospitalized patients - A french multicenter study [J].
Barbut, F ;
Corthier, G ;
Charpak, Y ;
Cerf, M ;
Monteil, H ;
Fosse, T ;
Trevoux, A ;
DeBarbeyrac, B ;
Boussougant, Y ;
Tigaud, S ;
Tytgat, F ;
Sedallian, A ;
Duborgel, S ;
Collignon, A ;
LeGuern, ME ;
Bernasconi, P ;
Petit, JC .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (13) :1449-1454
[2]   Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia [J].
Båverud, V ;
Franklin, A ;
Gunnarsson, A ;
Gustafsson, A ;
Hellander-Edman, A .
EQUINE VETERINARY JOURNAL, 1998, 30 (06) :482-488
[3]  
BUGGY BP, 1983, J CLIN MICROBIOL, V18, P348, DOI 10.1128/JCM.18.2.348-352.1983
[4]   Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility [J].
Butterworth, SA ;
Koppert, E ;
Clarke, A ;
Wiggs, B ;
MacFarlane, JK .
AMERICAN JOURNAL OF SURGERY, 1998, 175 (05) :403-407
[5]   INTERRELATIONSHIPS BETWEEN DIGESTIVE PROTEOLYTIC ACTIVITIES AND PRODUCTION AND QUANTITATION OF TOXINS IN PSEUDOMEMBRANOUS COLITIS INDUCED BY CLOSTRIDIUM-DIFFICILE IN GNOTOBIOTIC MICE [J].
CORTHIER, G ;
MULLER, MC ;
ELMER, GW ;
LUCAS, F ;
DUBOSRAMARE, F .
INFECTION AND IMMUNITY, 1989, 57 (12) :3922-3927
[6]   Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile [J].
Fedorko, DP ;
Williams, EC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1258-1259
[7]   DIAGNOSIS AND TREATMENT OF CLOSTRIDIUM-DIFFICILE COLITIS [J].
FEKETY, R ;
SHAH, AB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (01) :71-75
[8]  
Garcia A, 1997, J CLIN MICROBIOL, V35, P3007
[9]  
GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214
[10]   INFECTIOUS-DISEASES 1979 - ANTI-MICROBIAL AGENT-INDUCED COLITIS - UPDATE [J].
GEORGE, WL ;
ROLFE, RD ;
MULLIGAN, ME ;
FINEGOLD, SM .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (02) :266-268